File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Fulminant hepatic failure in nonmetastatic renal cell carcinoma

TitleFulminant hepatic failure in nonmetastatic renal cell carcinoma
Authors
Keywordsfulminant liver failure
renal cell carcinoma
Issue Date1992
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0163-2116
Citation
Digestive Diseases And Sciences, 1992, v. 37 n. 3, p. 474-477 How to Cite?
AbstractParaneoplastic manifestations including reversible abnormal serum liver biochemistry are known to occur in at least one third of patients with renal cell carcinoma. This hepatic dysfunction has always been regarded as benign in nature and attributed to reactive nonspecific hepatitis. In contrast to this belief, we report here a more devastating course of an asymptomatic patient with nonmetastatic renal cell carcinoma which ranged from mere serum liver biochemistry derangement to a fatal end with fulminant hepatic failure within 10 days. To our knowledge, this is the first report of such a case.
Persistent Identifierhttp://hdl.handle.net/10722/161921
ISSN
2021 Impact Factor: 3.487
2020 SCImago Journal Rankings: 1.140
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFang, JWSen_US
dc.contributor.authorLau, JYNen_US
dc.contributor.authorWu, PCen_US
dc.contributor.authorLai, CLen_US
dc.date.accessioned2012-09-05T05:16:02Z-
dc.date.available2012-09-05T05:16:02Z-
dc.date.issued1992en_US
dc.identifier.citationDigestive Diseases And Sciences, 1992, v. 37 n. 3, p. 474-477en_US
dc.identifier.issn0163-2116en_US
dc.identifier.urihttp://hdl.handle.net/10722/161921-
dc.description.abstractParaneoplastic manifestations including reversible abnormal serum liver biochemistry are known to occur in at least one third of patients with renal cell carcinoma. This hepatic dysfunction has always been regarded as benign in nature and attributed to reactive nonspecific hepatitis. In contrast to this belief, we report here a more devastating course of an asymptomatic patient with nonmetastatic renal cell carcinoma which ranged from mere serum liver biochemistry derangement to a fatal end with fulminant hepatic failure within 10 days. To our knowledge, this is the first report of such a case.en_US
dc.languageengen_US
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0163-2116en_US
dc.relation.ispartofDigestive Diseases and Sciencesen_US
dc.subjectfulminant liver failure-
dc.subjectrenal cell carcinoma-
dc.subject.meshAgeden_US
dc.subject.meshCarcinoma, Renal Cell - Complicationsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHepatic Encephalopathy - Etiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney Neoplasms - Complicationsen_US
dc.titleFulminant hepatic failure in nonmetastatic renal cell carcinomaen_US
dc.typeArticleen_US
dc.identifier.emailLai, CL:hrmelcl@hku.hken_US
dc.identifier.authorityLai, CL=rp00314en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1007/BF01307746-
dc.identifier.pmid1735373-
dc.identifier.scopuseid_2-s2.0-0026517204en_US
dc.identifier.volume37en_US
dc.identifier.issue3en_US
dc.identifier.spage474en_US
dc.identifier.epage477en_US
dc.identifier.isiWOS:A1992HF32000025-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridFang, JWS=7402963750en_US
dc.identifier.scopusauthoridLau, JYN=7402446047en_US
dc.identifier.scopusauthoridWu, PC=7403119323en_US
dc.identifier.scopusauthoridLai, CL=7403086396en_US
dc.identifier.issnl0163-2116-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats